Journal
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Volume 32, Issue -, Pages S197-S199Publisher
ELSEVIER
DOI: 10.1016/S0924-8579(09)70002-0
Keywords
Antibiotic resistance; Empirical therapy; Treatment options
Ask authors/readers for more resources
Multidrug microbial resistance poses major challenges to the management of infection, particularly with the paucity of new drugs with activity against these bacteria. Since the turn of this century a few new antibiotics have been licensed, including linezolid, daptomycin and tigecycline. This supplement reports data presented at the 13th International Congress of Infectious Diseases held in Kuala Lumpur in June 2008. Dr R. Isturiz reviews the data on global resistance trends and the potential impact on empirical therapy; Dr J.-H. Song reviews new agents on the antimicrobial horizon; and the. final paper in the supplement, by Dr L. R. Peterson, reviews the role of tigecycline in the management of complicated intra-abdominal and skin and soft tissue infections. (C) 2008 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available